Self-Reported Neuropsychiatric Post–COVID-19 Condition and CSF Markers of Neuroinflammation

This case-control study assesses cerebrospinal fluid markers of neuroinflammation and blood-brain barrier disruption in individuals with post–COVID-19 condition who reported neuropsychiatric symptoms.

Detalles Bibliográficos
Autores principales: Farhadian, Shelli F., Reisert, Hailey D., McAlpine, Lindsay, Chiarella, Jennifer, Kosana, Priya, Yoon, Jennifer, Spudich, Serena
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Medical Association 2023
Materias:
Research Letter
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10638645/
https://www.ncbi.nlm.nih.gov/pubmed/37948085
http://dx.doi.org/10.1001/jamanetworkopen.2023.42741
Descripción
Sumario:This case-control study assesses cerebrospinal fluid markers of neuroinflammation and blood-brain barrier disruption in individuals with post–COVID-19 condition who reported neuropsychiatric symptoms.

Ejemplares similares